|
108
|
348
|
9di9A |
Rat branched chain ketoacid dehydrogenase kinase in complex with inhibitor |
|
90
|
300
|
9cd5A |
Fgfr1 kinase domain soak with inhibitor tyra-300 |
|
88
|
305
|
9cd7A |
Fgfr3 kinase domain with inhibitor tyra-300 |
|
69
|
309
|
9c10B |
Amg 193, a clinical stage mta-cooperative prmt5 inhibitor, drives anti-tumor activity preclinically and in patients with mtap-deleted cancers |
|
190
|
625
|
9c10A |
Amg 193, a clinical stage mta-cooperative prmt5 inhibitor, drives anti-tumor activity preclinically and in patients with mtap-deleted cancers |
|
180
|
700
|
9ay9A |
Co-crystal structure of human prmt9 in complex with mrk-990 inhibitor |
|
109
|
318
|
8uoiA |
Crystal structure of human nuak1-mark3 kinase domain chimera bound with small molecule inhibitor #65 |
|
108
|
327
|
8uohA |
Crystal structure of human nuak1-mark3 kinase domain chimera bound with small molecule inhibitor #10 |
|
115
|
321
|
8uojA |
Crystal structure of human nuak1-mark3 kinase domain chimera bound with azepane (r)-#50 small molecule inhibitor |
|
105
|
320
|
8uolA |
Crystal structure of human nuak1-mark3 (6 mutations) kinase domain chimera bound with small molecule inhibitor #31 |
|
112
|
319
|
8uokA |
Crystal structure of human nuak1-mark3 (7 mutations) kinase domain chimera bound with small molecule inhibitor #31 |
|
110
|
350
|
8yd9A |
Crystal structure of p38alpha with an allosteric inhibitor 3 |
|
83
|
327
|
8xb1A |
Crystal structure of flt3 in complex with a pyrazinamide macrocycle derivative |
|
96
|
298
|
8w3dA |
Tas-120 covalent structure with fgfr2 molecular brake mutant |
|
90
|
298
|
8w38A |
Tas-120 covalent structure with fgfr2 molecular brake mutant |
|
89
|
314
|
8w2xA |
Tas-120 covalent structure with fgfr2 |
|
91
|
298
|
8w3bA |
Tas-120 covalent structure with fgfr2 molecular brake mutant |
|
78
|
242
|
8v74A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 10 |
|
77
|
242
|
8v79A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 15 |
|
79
|
242
|
8v71A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 7 |
|
79
|
242
|
8v70A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 6 |
|
80
|
242
|
8v6yA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 3 |
|
84
|
242
|
8v6xA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 2 |
|
81
|
242
|
8v75A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 11 |
|
80
|
242
|
8v76A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 12 |
|
79
|
242
|
8v6wA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 1 |
|
82
|
242
|
8v6zA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 4 |
|
79
|
242
|
8v78A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 14 |
|
81
|
242
|
8v72A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 8 |
|
77
|
242
|
8v73A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 9 |
|
80
|
242
|
8v77A |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 13 |
|
97
|
296
|
8scvA |
Crystal structure of irak4-hsa complexed with bms-986126; 6-((5-cyano-2-pyrimidinyl)amino)-n-((2r)-2-fluoro-3-hydroxhylbutyl)-4-(isopropylamino)nicotinamide |
|
94
|
296
|
8sceA |
Crystal structure of irak4-hsa complexed with n-[(2r)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyri-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
92
|
295
|
8scwA |
Crystal structure of irak4-hsa complexed with bms-986147; 6-{5-cyano-1h-pyrazolo[3,4-b]pyridin-1-yl}-n-[(2r)-2-fluorroxy-3-methylbutyl]-4-[(propan-2-yl)amino]pyridine-3-carboxamide |
|
77
|
295
|
8scvB |
Crystal structure of irak4-hsa complexed with bms-986126; 6-((5-cyano-2-pyrimidinyl)amino)-n-((2r)-2-fluoro-3-hydroxhylbutyl)-4-(isopropylamino)nicotinamide |
|
102
|
349
|
9o4lA |
Crystal structure of human p38 alpha mapk in complex with mw01-8 -066wh |
|
99
|
291
|
9blhA |
Crystal structure of calcium/calmodulin-dependent protein kinase type ii subunit delta complexed with ribociclib |
|
102
|
349
|
9y8bA |
Human p38 alpha mapk:mw164 pyridazine inhibitor complex |
|
75
|
265
|
9me2A |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound a110162 |
|
83
|
265
|
9me3A |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound p301390 |
|
84
|
266
|
9ejrA |
Bruton's tyrosine kinase in complex with compound pti52 |
|
77
|
265
|
9ejxA |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound pti42 |
|
83
|
265
|
9ejsA |
Bruton's tyrosine kinase with mutations in the activation loop in complex with compound pti52 |
|
80
|
266
|
9ejjA |
Bruton's tyrosine kinase in complex with compound pti55 |
|
37
|
145
|
9cr7A |
Structure of human setd8 in complex with covalent inhibitor am2928 |
|
103
|
347
|
8vxeA |
Structure of p38 alpha (mitogen-activated protein kinase 14) complexed with inhibitor 6 |
|
84
|
292
|
8vxdA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 7 |
|
87
|
293
|
8vxfB |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
89
|
295
|
8vxfA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
61
|
247
|
8u4wA |
The crystal structure of a helical domain deleted parp1 in complex with isoindolinone based inhibitor. |
